These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16014594)

  • 21. Impact of the single-dose immunization strategy against hepatitis A in Argentina.
    Vizzotti C; González J; Gentile A; Rearte A; Ramonet M; Cañero-Velasco MC; Pérez Carrega ME; Urueña A; Diosque M
    Pediatr Infect Dis J; 2014 Jan; 33(1):84-8. PubMed ID: 24352191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
    Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
    Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
    Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
    Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing epidemiology of viral hepatitis A in Israel.
    Green MS; Aharonowitz G; Shohat T; Levine R; Anis E; Slater PE
    Isr Med Assoc J; 2001 May; 3(5):347-51. PubMed ID: 11411199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
    Souto FJD; de Brito WI; Fontes CJF
    Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012.
    Levine H; Kopel E; Anis E; Givon-Lavi N; Dagan R
    Euro Surveill; 2015 Feb; 20(7):3-10. PubMed ID: 25719962
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).
    Erhart LM; Ernst KC
    Vaccine; 2012 Sep; 30(42):6103-10. PubMed ID: 22835739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
    Thompson C; Dey A; Fearnley E; Polkinghorne B; Beard F
    Vaccine; 2017 Jan; 35(1):170-176. PubMed ID: 27876203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?
    Martinelli D; Bitetto I; Tafuri S; Lopalco PL; Mininni RM; Prato R
    Vaccine; 2010 Sep; 28(41):6783-8. PubMed ID: 20688041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.
    Zhang ZL; Zhu XJ; Shan AL; Gao ZG; Zhang Y; Ding YX; Liu H; Wu WS; Liu Y; He HY; Xie XH; Xia WD; Li C; Xu WT; Li ZY; Lin HL; Fu WM
    Hum Vaccin Immunother; 2014; 10(4):1008-12. PubMed ID: 24503599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.
    Papaevangelou V; Alexopoulou Z; Hadjichristodoulou C; Kourlamba G; Katsioulis A; Theodoridou K; Spoulou V; Theodoridou M
    Hum Vaccin Immunother; 2016 Jul; 12(7):1852-6. PubMed ID: 27141813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis a vaccination coverage among children aged 24-35 months--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(6):141-4. PubMed ID: 15716804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Universal hepatitis A vaccination in Brazil: analysis of vaccination coverage and incidence five years after program implementation.
    Brito WI; Souto FJD
    Rev Bras Epidemiol; 2020; 23():e200073. PubMed ID: 32638856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of hepatitis A through routine vaccination of children.
    Averhoff F; Shapiro CN; Bell BP; Hyams I; Burd L; Deladisma A; Simard EP; Nalin D; Kuter B; Ward C; Lundberg M; Smith N; Margolis HS
    JAMA; 2001 Dec; 286(23):2968-73. PubMed ID: 11743837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
    Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
    Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
    Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
    Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A vaccination coverage among children aged 24-35 months--United States, 2004-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):678-81. PubMed ID: 17625495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.
    Stuurman AL; Marano C; Bunge EM; De Moerlooze L; Shouval D
    Hum Vaccin Immunother; 2017 Mar; 13(3):724-736. PubMed ID: 27786671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.